About Clinical Decision Support
The Clinical Decision Support category is part of the AI in Healthcare market map, tracking 17 companies building in this segment. Diagnostics, medical imaging, clinical AI, and remote monitoring transforming patient outcomes and healthcare delivery. Curated by Hartmann Capital's venture research team.
Companies in Clinical Decision Support
- OpenEvidence — Series C, $1.3B
- Regard — Series B, $81M
- Atropos Health — Series B, $33M
- ClosedLoop — Series B, $45M
- Cohere Health — Series C, $200M
- Hippocratic AI — Series C, $404M
- Hyro — Growth, $95M
- Innovaccer — Series F, $275M
- Biofourmis — Series D, $445M
- Verily — Growth, $1.7B
- Huma Therapeutics — Series D, $300M
- K Health — Series E, $271M
- Null Hypothesis — Series A
- Ascertain — Series A, $10M
- Fullpower-AI — Series B, $25M
- RhythmX AI — Seed, $50M
- Synthpop — Series A, $15M
Frequently Asked Questions
- What companies are in the Clinical Decision Support category?
- The Clinical Decision Support category includes 17 companies: OpenEvidence, Regard, Atropos Health, ClosedLoop, Cohere Health, Hippocratic AI, Hyro, Innovaccer, Biofourmis, Verily, Huma Therapeutics, K Health, Null Hypothesis, Ascertain, Fullpower-AI, RhythmX AI, Synthpop. This is part of the AI in Healthcare market map maintained by Hartmann Capital.
- How many Clinical Decision Support startups are tracked?
- Hartmann Capital tracks 17 companies in the Clinical Decision Support segment of the AI in Healthcare market map.
- What are the best funded Clinical Decision Support companies?
- Top funded companies in Clinical Decision Support include Verily ($1700M), OpenEvidence ($1335M), Biofourmis ($445M), Hippocratic AI ($404M), Huma Therapeutics ($300M). Browse the full list in the AI in Healthcare market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.